{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:08:01Z","timestamp":1790611681705,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04389-3","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T04:38:22Z","timestamp":1756183102000},"page":"467-472","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Postvaccine early-onset (PoVEO) forms of Graves\u2019 disease after anti-SARS-CoV-2 vaccination are characterized by favourable long-term disease outcomes"],"prefix":"10.1007","volume":"90","author":[{"given":"Luigi","family":"di Filippo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Acanfora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Vassallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Valsecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Castellino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford J.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6783-3398","authenticated-orcid":false,"given":"Andrea","family":"Giustina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"issue":"12","key":"4389_CR1","doi-asserted-by":"publisher","first-page":"CD015477","DOI":"10.1002\/14651858.CD015477","volume":"12","author":"C Gra\u00f1a","year":"2022","unstructured":"C. Gra\u00f1a, L. Ghosn, T. Evrenoglou et al., Efficacy and safety of COVID-19 vaccines. Cochrane Database Syst. Rev. 12(12), CD015477 (2022). https:\/\/doi.org\/10.1002\/14651858.CD015477.","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"4389_CR2","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12985-023-02103-1","volume":"20","author":"M Ziaka","year":"2023","unstructured":"M. Ziaka, A. Exadaktylos, Insights into SARS-CoV-2-associated subacute thyroiditis: from infection to vaccine. Virol. J. 20(1), 132 (2023). https:\/\/doi.org\/10.1186\/s12985-023-02103-1.","journal-title":"Virol. J."},{"issue":"1","key":"4389_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12020-021-02919-3","volume":"75","author":"L di Filippo","year":"2022","unstructured":"L. di Filippo, L. Castellino, A. Giustina, Occurrence and response to treatment of Graves\u2019 disease after COVID vaccination in two male patients. Endocrine 75(1), 19\u201321 (2022). https:\/\/doi.org\/10.1007\/s12020-021-02919-3.","journal-title":"Endocrine"},{"issue":"1","key":"4389_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jaut.2010.07.003","volume":"36","author":"Y Shoenfeld","year":"2011","unstructured":"Y. Shoenfeld, N. Agmon-Levin, \u2018ASIA\u2019 - autoimmune\/inflammatory syndrome induced by adjuvants. J. Autoimmun. 36(1), 4\u20138 (2011). https:\/\/doi.org\/10.1016\/j.jaut.2010.07.003.","journal-title":"J. Autoimmun."},{"issue":"6","key":"4389_CR5","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/cea.13874","volume":"51","author":"P Sellaturay","year":"2021","unstructured":"P. Sellaturay, S. Nasser, S. Islam, P. Gurugama, P.W. Ewan, Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer\/BioNTech mRNA COVID-19 vaccine. Clin. Exp. Allergy 51(6), 861\u2013863 (2021). https:\/\/doi.org\/10.1111\/cea.13874.","journal-title":"Clin. Exp. Allergy"},{"key":"4389_CR6","doi-asserted-by":"publisher","first-page":"617089","DOI":"10.3389\/fimmu.2020.617089","volume":"11","author":"A Vojdani","year":"2021","unstructured":"A. Vojdani, E. Vojdani, D. Kharrazian, Reaction of human monoclonal antibodies to SARS-CoV-2 proteins with tissue antigens: implications for autoimmune diseases. Front. Immunol. 11, 617089 (2021). https:\/\/doi.org\/10.3389\/fimmu.2020.617089.","journal-title":"Front. Immunol."},{"issue":"1","key":"4389_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-023-01387-2","volume":"23","author":"K Takedani","year":"2023","unstructured":"K. Takedani, M. Notsu, N. Ishiai, Y. Asami, K. Uchida, K. Kanasaki, Graves\u2019 disease after exposure to the SARS-CoV-2 vaccine: a case report and review of the literature. BMC Endocr. Disord. 23(1), 132 (2023). https:\/\/doi.org\/10.1186\/s12902-023-01387-2.","journal-title":"BMC Endocr. Disord."},{"issue":"2","key":"4389_CR8","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1210\/clinem\/dgad501","volume":"109","author":"I Muller","year":"2024","unstructured":"I. Muller, D. Consonni, E. Crivicich, F. Di Marco, N. Curr\u00f2, M. Salvi, Increased risk of thyroid eye disease following Covid-19 vaccination. J. Clin. Endocrinol. Metab. 109(2), 516\u2013526 (2024). https:\/\/doi.org\/10.1210\/clinem\/dgad501. published correction appears. J Clin Endocrinol Metab. 2024 May 17;109(6):e1480. doi: 10.1210\/clinem\/dgae064.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"4389_CR9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1210\/clinem\/dgac550","volume":"108","author":"L di Filippo","year":"2022","unstructured":"L. di Filippo, L. Castellino, A. Allora et al., Distinct clinical features of Post-COVID-19 vaccination early-onset Graves\u2019 disease. J. Clin. Endocrinol. Metab. 108(1), 107\u2013113 (2022). https:\/\/doi.org\/10.1210\/clinem\/dgac550.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"4389_CR10","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1089\/thy.2016.0229","volume":"26","author":"DS Ross","year":"2016","unstructured":"D.S. Ross, H.B. Burch, D.S. Cooper et al., 2016 American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 26(10), 1343\u20131421 (2016). https:\/\/doi.org\/10.1089\/thy.2016.0229. published correction appears in Thyroid. 2017 Nov;27(11):1462. doi: 10.1089\/thy.2016.0229.correx.","journal-title":"Thyroid"},{"issue":"2","key":"4389_CR11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s12020-021-02734-w","volume":"72","author":"M Puig-Domingo","year":"2021","unstructured":"M. Puig-Domingo, M. Marazuela, B.O. Yildiz, A. Giustina, COVID-19 and endocrine and metabolic diseases. An updated statement from the European society of endocrinology. Endocrine 72(2), 301\u2013316 (2021). https:\/\/doi.org\/10.1007\/s12020-021-02734-w.","journal-title":"Endocrine"},{"issue":"1","key":"4389_CR12","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s12020-020-02294-5","volume":"68","author":"M Puig-Domingo","year":"2020","unstructured":"M. Puig-Domingo, M. Marazuela, A. Giustina, COVID-19 and endocrine diseases. A statement from the European society of endocrinology. Endocrine 68(1), 2\u20135 (2020). https:\/\/doi.org\/10.1007\/s12020-020-02294-5.","journal-title":"Endocrine"},{"issue":"2","key":"4389_CR13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s12020-022-03135-3","volume":"78","author":"L di Filippo","year":"2022","unstructured":"L. di Filippo, S. Frara, M. Doga, A. Giustina, The osteo-metabolic phenotype of COVID-19: an update. Endocrine 78(2), 247\u2013254 (2022). https:\/\/doi.org\/10.1007\/s12020-022-03135-3.","journal-title":"Endocrine"},{"issue":"8","key":"4389_CR14","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/s41574-021-00516-y","volume":"17","author":"L di Filippo","year":"2021","unstructured":"L. di Filippo, S. Frara, A. Giustina, The emerging osteo-metabolic phenotype of COVID-19: clinical and pathophysiological aspects. Nat. Rev. Endocrinol. 17(8), 445\u2013446 (2021). https:\/\/doi.org\/10.1038\/s41574-021-00516-y.","journal-title":"Nat. Rev. Endocrinol."},{"issue":"3","key":"4389_CR15","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s11102-021-01148-1","volume":"24","author":"S Frara","year":"2021","unstructured":"S. Frara, A. Allora, L. Castellino, L. di Filippo, P. Loli, A. Giustina, COVID-19 and the pituitary. Pituitary 24(3), 465\u2013481 (2021). https:\/\/doi.org\/10.1007\/s11102-021-01148-1.","journal-title":"Pituitary"},{"issue":"2","key":"4389_CR16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/BOR.0000000000000776","volume":"33","author":"Y Liu","year":"2021","unstructured":"Y. Liu, A.H. Sawalha, Q. Lu, COVID-19 and autoimmune diseases. Curr. Opin. Rheumatol. 33(2), 155\u2013162 (2021). https:\/\/doi.org\/10.1097\/BOR.0000000000000776.","journal-title":"Curr. Opin. Rheumatol."},{"key":"4389_CR17","doi-asserted-by":"publisher","first-page":"103070","DOI":"10.1016\/j.jaut.2023.103070","volume":"139","author":"M Rojas","year":"2023","unstructured":"M. Rojas, M. Herr\u00e1n, C. Ram\u00edrez-Santana et al., Molecular mimicry and autoimmunity in the time of COVID-19. J. Autoimmun. 139, 103070 (2023). https:\/\/doi.org\/10.1016\/j.jaut.2023.103070.","journal-title":"J. Autoimmun."},{"issue":"7","key":"4389_CR18","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1177\/10815589231173876","volume":"71","author":"E Markus","year":"2023","unstructured":"E. Markus, A. Bel-Ange, C. Benbassat, M. Steinschneider, R. Koren, Short- and long-term outcomes of patients with hyper or hypothyroidism following COVID vaccine. J. Investig. Med. 71(7), 700\u2013706 (2023). https:\/\/doi.org\/10.1177\/10815589231173876.","journal-title":"J. Investig. Med."},{"issue":"1","key":"4389_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.5935\/1984-0063.20180008","volume":"11","author":"S Leiva","year":"2018","unstructured":"S. Leiva, J. Madrazo, C. Podesta, Narcolepsy with cataplexy and hyperthyroidism sudden appeared after H1N1 vaccination. Sleep. Sci. 11(1), 34\u201336 (2018). https:\/\/doi.org\/10.5935\/1984-0063.20180008.","journal-title":"Sleep. Sci."},{"issue":"1","key":"4389_CR20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s12026-016-8811-0","volume":"65","author":"LJ Jara","year":"2017","unstructured":"L.J. Jara, G. Garc\u00eda-Collinot, G. Medina et al., Severe manifestations of autoimmune syndrome induced by adjuvants (Shoenfeld\u2019s syndrome). Immunol. Res. 65(1), 8\u201316 (2017). https:\/\/doi.org\/10.1007\/s12026-016-8811-0.","journal-title":"Immunol. Res."},{"issue":"1","key":"4389_CR21","doi-asserted-by":"publisher","first-page":"101412","DOI":"10.1016\/j.beem.2020.101412","volume":"34","author":"NL Bragazzi","year":"2020","unstructured":"N.L. Bragazzi, A. Hejly, A. Watad, M. Adawi, H. Amital, Y. Shoenfeld, ASIA syndrome and endocrine autoimmune disorders. Best. Pract. Res. Clin. Endocrinol. Metab. 34(1), 101412 (2020). https:\/\/doi.org\/10.1016\/j.beem.2020.101412.","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"issue":"1","key":"4389_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-023-01424-0","volume":"23","author":"AS Alsudais","year":"2023","unstructured":"A.S. Alsudais, R.S. Alkanani, A.B. Fathi et al., Autoimmune diabetes mellitus after COVID-19 vaccination in adult population: a systematic review of case reports. BMC Endocr. Disord. 23(1), 164 (2023). https:\/\/doi.org\/10.1186\/s12902-023-01424-0.","journal-title":"BMC Endocr. Disord."},{"issue":"1","key":"4389_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s12020-022-03130-8","volume":"78","author":"Aydo\u011fan B\u0130","year":"2022","unstructured":"Aydo\u011fan B\u0130, U. \u00dcnl\u00fct\u00fcrk, M. Cesur, Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination. Endocrine 78(1), 42\u201346 (2022). https:\/\/doi.org\/10.1007\/s12020-022-03130-8.","journal-title":"Endocrine"},{"issue":"5","key":"4389_CR24","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1007\/s10067-022-06149-4","volume":"41","author":"LJ Jara","year":"2022","unstructured":"L.J. Jara, O. Vera-Lastra, N. Mahroum, C. Pineda, Y. Shoenfeld, Autoimmune post-COVID vaccine syndromes: does the spectrum of autoimmune\/inflammatory syndrome expand?. Clin. Rheumatol. 41(5), 1603\u20131609 (2022). https:\/\/doi.org\/10.1007\/s10067-022-06149-4.","journal-title":"Clin. Rheumatol."},{"issue":"4","key":"4389_CR25","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/imm.13443","volume":"165","author":"Y Chen","year":"2022","unstructured":"Y. Chen, Z. Xu, P. Wang et al., New-onset autoimmune phenomena post-COVID-19 vaccination. Immunology 165(4), 386\u2013401 (2022). https:\/\/doi.org\/10.1111\/imm.13443.","journal-title":"Immunology"},{"issue":"2","key":"4389_CR26","doi-asserted-by":"publisher","first-page":"e508","DOI":"10.1210\/clinem\/dgad582","volume":"109","author":"A Gorshtein","year":"2024","unstructured":"A. Gorshtein, A. Turjeman, H. Duskin-Bitan, L. Leibovici, E. Robenshtok, Graves\u2019 disease following COVID-19 vaccination: a population-based, matched case-control study. J. Clin. Endocrinol. Metab. 109(2), e508\u2013e512 (2024). https:\/\/doi.org\/10.1210\/clinem\/dgad582.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"4389_CR27","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.eprac.2023.05.005","volume":"29","author":"M Endo","year":"2023","unstructured":"M. Endo, J. Pinto, M.Y. Roth, A.N. Hoofnagle, R.A. Failor, T.S. Tylee, The incidence of Graves\u2019 hyperthyroidism before and after COVID-19 messenger RNA vaccination. Endocr. Pract. 29(8), 618\u2013622 (2023). https:\/\/doi.org\/10.1016\/j.eprac.2023.05.005.","journal-title":"Endocr. Pract."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04389-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04389-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04389-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T11:07:39Z","timestamp":1761736059000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04389-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["4389"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04389-3","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"3 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"TAndrea Giustina is consultant for Abiogen and received research grant to Institution from Takeda. Luigi di Filippo received research grant to Institution from Abiogen and his research activities are partly supported by Glucocorticoid induced Osteoporosis Skeletal (GIOSEG). All other authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}